MX2019001981A - Pparï’ agonist for treatment of bone disorders. - Google Patents

Pparï’ agonist for treatment of bone disorders.

Info

Publication number
MX2019001981A
MX2019001981A MX2019001981A MX2019001981A MX2019001981A MX 2019001981 A MX2019001981 A MX 2019001981A MX 2019001981 A MX2019001981 A MX 2019001981A MX 2019001981 A MX2019001981 A MX 2019001981A MX 2019001981 A MX2019001981 A MX 2019001981A
Authority
MX
Mexico
Prior art keywords
pparï
treatment
agonist
bone disorders
disorders
Prior art date
Application number
MX2019001981A
Other languages
Spanish (es)
Inventor
Lanfear Dennis
Original Assignee
Intekrin Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intekrin Therapeutics Inc filed Critical Intekrin Therapeutics Inc
Priority claimed from PCT/US2017/047584 external-priority patent/WO2018035449A1/en
Publication of MX2019001981A publication Critical patent/MX2019001981A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Methods of treatment of bone disorders, including osteoporosis or its symptoms, with PPARÏ’ agonists, and in particular, the compound of formula (I) known as INT131 : (I).
MX2019001981A 2017-08-18 2017-08-18 Pparï’ agonist for treatment of bone disorders. MX2019001981A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2017/047584 WO2018035449A1 (en) 2016-08-18 2017-08-18 Pparϒ agonist for treatment of bone disorders
US201862376732P 2018-08-18 2018-08-18

Publications (1)

Publication Number Publication Date
MX2019001981A true MX2019001981A (en) 2019-09-19

Family

ID=68728586

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019001981A MX2019001981A (en) 2017-08-18 2017-08-18 Pparï’ agonist for treatment of bone disorders.

Country Status (1)

Country Link
MX (1) MX2019001981A (en)

Similar Documents

Publication Publication Date Title
PH12018501226A1 (en) Methods for treating huntingtons disease
MX2018006217A (en) Apelin receptor agonists and methods of use.
MX2023004593A (en) Tyk2 inhibitors and uses thereof.
MX2019014514A (en) Compounds for treating huntington's disease.
SG10201903823QA (en) Methods and compositions relating to microbial treatment and diagnosis of disorders
NZ724878A (en) Compounds and compositions as toll-like receptor 7 agonists
PH12015502788A1 (en) Antibody formulations and methods
MX2018007155A (en) Heteroarylhydroxypyrimidinones as agonists of the apj receptor.
CL2016003422A1 (en) Lysine specific demethylase-1 inhibitors
EA201691134A1 (en) NEW GLUTAMINASE INHIBITORS
MY202336A (en) Agonist antibodies that bind human cd137 and uses thereof
MX2015012502A (en) Dna-pk inhibitors.
MX2015011898A (en) Pyrazolo compounds and uses thereof.
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
CL2016003423A1 (en) Lysine specific demethylase-1 inhibitors
MX2018006632A (en) Bicyclic inhibitors of pad4.
NZ763528A (en) Heterocyclic gpr119 agonist compounds
MX2018006700A (en) Aza-benzimidazole inhibitors of pad4.
PH12018500887A1 (en) Anti-htra1 antibodies and methods of use thereof
MX2017015225A (en) Autotaxin inhibitors and uses thereof.
MX2015009818A (en) Pparî³ agonists for treatment of multiple sclerosis.
MX2020002216A (en) Methods and compositions for detecting and treating endometriosis.
TW201613878A (en) Pyrazine GPR40 agonists for the treatment of type II diabetes
MX2021001471A (en) Substituted benzimidazoles as pad4 inhibitors.